PE20061162A1 - Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos - Google Patents
Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanosInfo
- Publication number
- PE20061162A1 PE20061162A1 PE2005001395A PE2005001395A PE20061162A1 PE 20061162 A1 PE20061162 A1 PE 20061162A1 PE 2005001395 A PE2005001395 A PE 2005001395A PE 2005001395 A PE2005001395 A PE 2005001395A PE 20061162 A1 PE20061162 A1 PE 20061162A1
- Authority
- PE
- Peru
- Prior art keywords
- endo
- dimethyl
- octane
- bromide
- azoniabiciclo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- -1 2-THENYL Chemical class 0.000 abstract 4
- 229940124225 Adrenoreceptor agonist Drugs 0.000 abstract 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010014561 Emphysema Diseases 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 1
- 229960004373 acetylcholine Drugs 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 abstract 1
- BDDIUTHMWNWMRJ-UHFFFAOYSA-N octane;hydrobromide Chemical compound Br.CCCCCCCC BDDIUTHMWNWMRJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE R2 Y R3 SON ALQUILO(C1-C6), CICLOALQUILO(C5-C6), 2-TIENILO, 2-PIRIDILO, ENTRE OTROS; X- ES UN ANION ASOCIADO CON LA CARGA POSITIVA DEL ATOMO DE N TAL COMO CLORURO, BROMURO, YODURO, SULFATO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: BROMURO DE (3-ENDO)-3-(2,2-DI-2-TIENILETENIL)-8,8-DIMETIL-8-AZONIABICICLO[3.2.1]OCTANO, BROMURO DE (3-ENDO)-3-(2,2DIFENILETENIL)-8,8-DIMETIL-8-AZONIABICICLO[3.2.1]OCTANO, 4-METILBENCENOSULFONATO DE (3-ENDO)-3-(2,2-DIFENILETENIL)-8,8-DIMETIL-8-AZONIABICICLO[3.2.1]OCTANO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE ADEMAS CONTIENE UN AGONISTA DEL ADRENORECEPTOR ß2, UN ANTIHISTAMINICO, UN ANTIALERGICO O UN ANTIINFLAMATORIO. DICHOS COMPUESTOS INHIBEN LA UNION DE ACETILCOLINA A SUS RECEPTORES MUSCARINICOS SIENDO UTILES EN EL TRATAMIENTO DE ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA, BRONQUITIS CRONICA, ASMA, FIBROSIS PULMONAR, ENFISEMA PULMONAR
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63366904P | 2004-12-06 | 2004-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061162A1 true PE20061162A1 (es) | 2006-10-14 |
Family
ID=36578446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001395A PE20061162A1 (es) | 2004-12-06 | 2005-12-01 | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR054411A1 (es) |
| PE (1) | PE20061162A1 (es) |
| TW (1) | TW200633706A (es) |
| UY (1) | UY29244A1 (es) |
| WO (1) | WO2006062883A2 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20050250A1 (es) | 2003-07-17 | 2005-04-08 | Glaxo Group Ltd | Antagonistas de los receptores muscarinicos de la acetilcolina |
| KR20060106821A (ko) | 2003-10-14 | 2006-10-12 | 글락소 그룹 리미티드 | 무스카린성 아세틸콜린 수용체 길항제 |
| AU2004281167A1 (en) | 2003-10-17 | 2005-04-28 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists field of the invention |
| TW200524577A (en) | 2003-11-04 | 2005-08-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| WO2005095407A1 (en) | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| AR050902A1 (es) | 2004-04-27 | 2006-12-06 | Glaxo Group Ltd | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion |
| US7598267B2 (en) | 2004-05-13 | 2009-10-06 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| JP2008520579A (ja) | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| WO2007022351A2 (en) | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| TW200946525A (en) | 2008-02-06 | 2009-11-16 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
| TW201000476A (en) | 2008-02-06 | 2010-01-01 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
| UY31635A1 (es) | 2008-02-06 | 2009-08-31 | Farmacóforos duales-antagonistas muscarínicos de pde4 | |
| LT3578169T (lt) | 2009-02-26 | 2024-08-26 | Glaxo Group Limited | Farmaciniai preparatai, apimantys 4-{(1r)-2-[(6-{2-[(2,6-dichlorbenzil) oksi]etoksi}heksil)amino]-1-hidroksietil}-2-(hidroksimetil)fenolį |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| AU2013246926B2 (en) | 2012-04-13 | 2016-07-21 | Glaxosmithkline Intellectual Property Development Limited | Aggregate particles |
| GB201222679D0 (en) * | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2800478A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
| GB1273823A (en) * | 1968-10-22 | 1972-05-10 | Soc Ind Fab Antibiotiques Sifa | New tropane derivatives their salts and process for preparation thereof |
| IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
| US6624167B1 (en) * | 2000-08-04 | 2003-09-23 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
-
2005
- 2005-12-01 PE PE2005001395A patent/PE20061162A1/es not_active Application Discontinuation
- 2005-12-02 UY UY29244A patent/UY29244A1/es unknown
- 2005-12-05 TW TW094142713A patent/TW200633706A/zh unknown
- 2005-12-05 WO PCT/US2005/043875 patent/WO2006062883A2/en active Application Filing
- 2005-12-05 AR ARP050105078A patent/AR054411A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY29244A1 (es) | 2006-05-31 |
| WO2006062883A2 (en) | 2006-06-15 |
| WO2006062883A3 (en) | 2007-03-29 |
| TW200633706A (en) | 2006-10-01 |
| AR054411A1 (es) | 2007-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20061162A1 (es) | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos | |
| PE20060259A1 (es) | Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico | |
| PE20050327A1 (es) | Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de los receptores muscarinicos de la acetilcolina | |
| PE20050489A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos | |
| PE20110829A1 (es) | Derivados aminoester de alcaloides y composicion medicinal de los mismos | |
| PE20080407A1 (es) | Derivados de quinuclidina como antagonistas de m3 | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| PE20061439A1 (es) | DERIVADOS DE 2-AMIDO-6-AMINO-8-OXO-PURINA COMO MODULADORES DEL RECEPTOR Toll (TLR) | |
| NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
| PE20080406A1 (es) | Pirazoles como activadores de glucoquinasa | |
| EA200500814A1 (ru) | Производные пирролопиримидина | |
| MY136034A (en) | New medicaments for the treatment of chronic obstructive pulmonary disease | |
| PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
| PE20091376A1 (es) | Derivados de fenilamino como moduladores de beta-amiloide | |
| AR054481A1 (es) | Derivados de 2-azetidinonas como inhibidores de la absorcion de colesterol | |
| PE20090362A1 (es) | Derivados de piperidina/piperazina como moduladores de dgat | |
| UA94606C2 (ru) | Производные тиоксантина, композиция, которая их содержит, и их применение в терапии | |
| DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
| TW200519091A (en) | Dihydropyridine compounds for treating or preventing metabolic disorders | |
| PE20110807A1 (es) | Inhibidores de cinasa akt y p70 s6 | |
| PE20070460A1 (es) | Derivados de carboxamida como antagonista del receptor muscarinico | |
| WO2007020261A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| MX2007004197A (es) | Antagonistas del receptor de trombina. | |
| PE20050711A1 (es) | Compuestos 8-azoniabiciclo[3.2.1] octanos como antagonistas de los receptores muscarinicos de la acetilcolina | |
| PE20090357A1 (es) | Compuestos heterociclicos con actividad sobre los receptores muscarinicos m3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |